Blood Eosinophils and Exhaled Nitric Oxide: Surrogate Biomarkers of Airway Eosinophilia in Stable COPD and Exacerbation
In recent years, tremendous efforts have been devoted to characterizing the inflammatory processes in chronic obstructive pulmonary disease (COPD) in order to provide more personalized treatment for COPD patients. While it has proved difficult to identify COPD-specific inflammatory pathways, the dis...
Main Authors: | Balazs Antus, Imre Barta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/9/2128 |
Similar Items
-
Predictive Value of Exhaled Nitric Oxide and Blood Eosinophil Count in the Assessment of Airway Eosinophilia in COPD
by: Antus B, et al.
Published: (2020-08-01) -
Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD
by: Negewo NA, et al.
Published: (2016-07-01) -
Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD
by: Gao J, et al.
Published: (2017-04-01) -
Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD
by: Celejewska-Wójcik N, et al.
Published: (2021-05-01) -
Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts
by: Müllerová H, et al.
Published: (2019-03-01)